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In assessing the potential of predatory bacteria, such as Bdellovibrio bacteriovorus, to become live 
therapeutic agents against bacterial infections, it is crucial to understand and quantify Bdellovibrio 
host cell interactions at a molecular level. Here, we quantify the interactions of live B. bacteriovorus 
with human phagocytic cells, determining the uptake mechanisms, persistence, associated cytokine 
responses and intracellular trafficking of the non-growing B. bacteriovorus in PMA-differentiated 
U937 cells. B. bacteriovorus are engulfed by U937 cells and persist for 24 h without affecting host cell 
viability and can be observed microscopically and recovered and cultured post-uptake. the uptake of 
predators is passive and depends on the dynamics of the host cell cytoskeleton; the engulfed predators 
are eventually trafficked through the phagolysosomal pathway of degradation. We have also studied 
the prevalence of B. bacteriovorus specific antibodies in the general human population. Together, these 
results quantify a period of viable persistence and the ultimate fate of B. bacteriovorus inside phagocytic 
cells. they provide new knowledge on predator availability inside hosts, plus potential longevity and 
therefore potential efficacy as a treatment in humans and open up future fields of work testing if 
predators can prey on host-engulfed pathogenic bacteria.
In response to the emergence of antimicrobial-resistant bacterial infections as a global health issue, several alter-
native, non-small molecule measures, are being sought to treat drug resistant bacterial infections1–4. One such 
approach is the potential use of living predatory bacteria such as Bdellovibrio bacteriovorus4–7, a Gram-negative 
predatory bacterium, which invades and preys upon a wide range of Gram-negative bacteria in their natural 
environments that are soil and water6. In in vitro conditions, B. bacteriovorus can prey upon and kill several 
Gram-negative pathogenic bacteria, irrespective of their antibiotic resistance profile8 and more recently, the sus-
ceptibility of these pathogens to predation has been shown in vivo9–11. Recent studies have verified the apparent 
safety of predators using in vitro cell culture12–14 and in vivo animal models9–11,14–18. The questions that remain to 
be addressed are with regard to their interactions as living, but seemingly non-pathogenic bacteria, with the host 
immune system, which involves evaluation of the mechanisms of uptake and persistence of predatory bacteria 
within phagocytes and the processes involved in their clearance from these host cells. Also it is not known how 
frequently the human immune system encounters predatory bacteria in normal life.
All micro-organisms, including bacterial pathogens, encounter professional phagocytic cells such as mac-
rophages and dendritic cells which are the first line of defence and the essential components of the innate immune 
system19,20. These host cells engulf and ingest internalised micro-organisms through phagocytosis, a process 
driven by receptor-ligand interactions resulting in cytoskeletal remodelling and engulfment of targets by pseu-
dopods. Phagocytosis culminates in the formation of sealed intracellular compartments, namely, phagosomes 
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that harbour the ingested bacteria19–21. The nascent phagosome matures into an organelle with microbiocidal 
properties through its complex interactions with the endolysosomal network, a process that involves sequential 
acquisition of different proteins of the endocytic pathway and ultimately results in fusion of phagosomes with lys-
osomes to form phagolysosomes with an acidic pH facilitating bacterial killing and degradation19,21. Phagosomal 
maturation also routes antigens for presentation with MHC molecules to the helper T cells resulting in adaptive 
immune response through T and B cell activation22.
Our previous work in zebrafish model showed that the injected B. bacteriovorus became localised with fish 
macrophages over time10. However, in that study, the duration of persistence and fate of B. bacteriovorus inside 
phagocytic cells could not be readily determined. In the current study, we were interested in understanding the 
timescale of persistence and dynamics of B. bacteriovorus clearance from the phagocytes and its impact on pred-
ator availability for potential pathogen clearance in vivo. Being mindful of the mechanisms adopted by replicative 
pathogens to evade or combat phagocytic activities of the innate immune cells to prolong their survival19,20,23,24, 
we wished to investigate whether predatory B. bacteriovorus, which do not replicate without bacterial prey25, 
interfere with phagosomal maturation to promote their own survival.
Although there are helpful studies evaluating the cytotoxicity and cytokine responses induced by B. bacterio-
vorus in vitro in human monocyte and epithelial cell lines12–14, visualising, recovering and enumerating viable B. 
bacteriovorus from phagocytic cells in combination with the analysis of their phagosomal interactions and fate 
inside these cells are experimental challenges that have not yet been addressed. Such data will not only profile 
predator availability in vivo, but eventually aid in the assessment of the potential of predatory bacteria to meet and 
prey on intracellular pathogens, such as Salmonella, Klebsiella and Francisella species, inside cells. There needs 
to be a better understanding of predator persistence in different host environments and verification of duration 
of predator availability, in vivo, if employed as a future therapeutic. This requires reliable enumeration of live B. 
bacteriovorus during pathogen-treatment or predator-interaction alone with immune cells. Even though preda-
tor enumeration can be challenging in in vivo studies, recently we have sought ways to quantify predators in our 
studies in the zebrafish model10 as well as in the current study.
PMA-differentiated U937 cells have been used for studying interactions and intracellular trafficking of several 
Gram-negative pathogens within macrophages26–29 and we adopted similar methodology to study the interactions 
of B. bacteriovorus predators with these human phagocytic cells. We counted predatory bacteria internalised 
by the phagocytic cells and assessed their persistence and effects on host cell viability, intracellular trafficking 
of predators, the role of cytoskeleton in their uptake, and the associated immune responses. We also assayed B. 
bacteriovorus-reactive antibodies in human serum samples from normal human populations to report and to 
predict longevity of an injected treatment.
Results
B. bacteriovorus persist live inside U937 cells. To test for potential engulfment of B. bacteriovorus by 
PMA-differentiated U937 macrophage-like cells (denoted as U937 cells throughout the manuscript for ease of 
reading), B. bacteriovorus HD100 (BbHD100) or cerulean-fluorescent B. bacteriovorus HD100 (BbHD100CFP) 
predators were exposed to U937 cells for 2 h at multiplicity of exposures (MOEs) of 50 or 10 bacteria per U937 cell 
(denoted as 50:1 or 10:1) and free bacteria were removed by washing (Direct 2 h uptake, see Fig. S1 for protocol 
scheme). Predatory bacteria engulfed by the macrophages were recovered following experimental lysis of the 
U937 cells, and enumerated by viable plaque counts (on prey bacterial lawns), In parallel experiments, engulfed 
predatory bacteria were observed and counted in whole U937 cells by fluorescence microscopy (Fig. 1). In all the 
experiments described, time “zero” corresponds to the start of the experiment when the incubation of U937 cells 
with B. bacteriovorus at 37 °C, 5% CO2 commenced. At both MOEs tested, after washing, live U937-associated 
BbHD100 could be recovered and enumerated by bacterial-plaque assay at 2, 4, 8, 24 and 48 h (Fig. 1(a)). The 
numbers of viable bacteria recovered decreased from 2 to 48 h (Fig. 1(a)). The highest numbers of predatory bac-
teria intracellular to U937 cells were recovered at 2 h at both MOEs with, as expected, significantly higher plaque 
recovery at MOE 50:1 (P = 0.0002, Fig. 1(a)). The predatory bacteria persisted and were able to survive within 
U937 cells at relatively high numbers for up to 8 h (Fig. 1(a), 1–7 × 104 Plaque-forming units (PFU)/mL at 8 h. 
At 24 h, the predator numbers reduced by greater than one-log in comparison to those recovered at 8 h (for both 
MOEs, P = 0.0002) and at 48 h, less than 40 PFU of bacteria were recovered at both MOEs (Fig. 1(a)). Raw data 
points comprising Fig. 1(a) are shown in Fig. S2.
To confirm the intracellular location of BbHD100 after 2 h direct uptake as described above, in a separate 
experiment BbHD100 exposed U937 cells were treated with gentamycin 50 µg/mL for 2 h (the concentration 
at which B. bacteriovorus are killed at both MOEs in cell culture medium after 2 h incubation, data not shown). 
BbHD100 were recovered from the gentamycin-treated U937 cells and the viable predators were enumerated by 
bacterial-plaque assay and compared to the viable BbHD100 recovered from non-gentamycin treated BbHD100 
exposed U937 cells at 4 h. BbHD100 recovered at 4 h after gentamycin treatment was not significantly different 
from that recovered from non-gentamycin treated U937 cells from which we concluded that B. bacteriovorus 
recovered at 4 h were indeed intracellular (for 4 h versus 4 h with gentamycin treatment, P = 0.6181, data not 
shown).
We observed BbHD100CFP intracellular to U937 cells by fluorescence widefield microscopy, at 2, 4, 8 and 
24 h at both the MOEs tested (data shown for time points 2 and 24 h at MOE 50:1, Fig. 1(b)). We further con-
firmed the intracellular location of B. bacteriovorus at 2 h by confocal microscopic imaging and 3D visualis-
ation of microtubule-stained, U937 cells, with Teal-fluorescent B. bacteriovorus HD100 (BbHD100TFP) (Fig. S3, 
Video S1). We counted the observed tiny individual predatory bacteria at 2 h and 24 h, (for samples applied 
at a MOE of 50:1), using z-stack images taken through U937 cells by fluorescence widefield microscopy and 
could detect variable numbers of B. bacteriovorus per U937 cell ranging from 1 to 50 at both the time points 
(Fig. 1(c)). Even though we were unable to determine bacterial viability microscopically by live-dead staining of 
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BbHD100CFP, we observed persistence with a small decrease in the median B. bacteriovorus number per U937 
cell counted from 15 ± 9.228 at 2 h to 10 ± 10.13 at 24 h (Fig. 1(c), P < 0.0060) supporting the drop observed 
in total viable bacterial recovery in the above experiments from 2 h to 24 h. Taken together these experimental 
approaches demonstrate the persistence of viable B. bacteriovorus inside the U937 cells for many hours.
Cytoskeletal dynamics of the U937 cells regulate the uptake of B. bacteriovorus. As we were able 
to detect and recover live B. bacteriovorus from inside U937 cells, we next investigated the molecular mechanisms 
used by these phagocytic cells to take up the predatory bacteria. Pathogenic bacteria often can exploit the actin 
Figure 1. Persistence and survival of B. bacteriovorus inside U937 cells. (a) BbHD100 were exposed to U937 
cells for 2 h at MOEs of 50:1 and 10:1. The predatory bacteria recovered from the U937 cells were enumerated 
at 2, 4, 8, 24 and 48 h. Data shown, as PFU/mL, are representative of mean ± standard deviation of two 
independent experiments, each set up in duplicate for U937-HD100 exposures and included technical replicates 
for bacterial-plaque enumerations (n = 8). ***corresponds to P = 0.0002. (b) Representative images of U937 
cells containing BbHD100CFP at 2 and 24 hours. BbHD100CFP were exposed to U937 cells for 2 hours at a 
MOE of 50:1 and the U937 cells with predatory bacteria were fixed at 2 and 24 h. The images shown constitute 
whole cells (phase), snapshots of nuclei (stained with SiR-DNA, red) and maximum intensity 2D-projections 
of restored z-stack images of BbHD100CFP (blue). Scale bar −10 µm. Images are representative of two 
independent experiments, each set up in duplicate. In analysing images, no BbHD100CFP were observed as 
attached to the outside of the cells after the 2 h uptake. (c) BbHD100CFP inside U937 cells were counted from 
the restored z-stack images of fixed U937 cells with BbHD100CFP at 2 and 24 h from MOE 50:1 exposures. 
Data shown, as number of BbHD100CFP visualised per cell, are representative of one of the two independent 
experiments, each set up in duplicate and a minimum of 150 cells were analysed at each time point from each 
experiment (n = 150 cells per experiment). **corresponds to P = 0.0060.
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Figure 2. Role of cytoskeleton in the uptake of B. bacteriovorus by U937 cells. (a) U937 cells pretreated with 
actin depolymerising agent, cytochalasin D (10 µM) for 1 h were exposed to BbHD100TFP (green) for 2 h at an 
MOE of 50 bacteria per cell in the presence of inhibitors or carrier (DMSO) and fixed. The actin filaments of 
fixed cells were stained with Rhodamine-phalloidin (false coloured in cyan), the nuclei were stained with SiR-
DNA (red) and imaged. Shown are the maximum intensity 2D-projections (Stacks 1–20 used for both control 
and cytochalasin D treated cells) of the restored z-stack images. Scale bar −5 µm. Images are representative of 
two independent experiments. (b) U937 cells pretreated with microtubule inhibitor, Nocodazole (2.5 µM) for 
1 h were exposed to BbHD100TFP (green) for 2 h at a MOE of 50 bacteria per cell in the presence of inhibitor 
or carrier (DMSO) and fixed. The microtubules of the fixed cells were stained with anti-tubulin primary 
antibody and Alexa 555 secondary antibody (false coloured in magenta), nuclei were stained with SiR-DNA 
(red) and imaged. Shown are the maximum intensity 2D-projections (Stacks 5–25 for both control and 
Nocodazole treated cells) of the restored images. Scale bar −5 µm. Images are representative of two independent 
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and microtubules of the host cell cytoskeleton to their advantage using secreted effectors to facilitate their uptake 
and intracellular survival30–32, however, whether non-pathogenic, predatory B. bacteriovorus use any similar strat-
egy has not been addressed.
To investigate the nature of B. bacteriovorus uptake and survival, we used U937 cells in which F-actin had 
been depolymerised using cytochalasin D (CD), or in which microtubules had been disassembled with nocoda-
zole (Ndz) alongside control U937 cells treated with carrier, DMSO. Although uptake was not completely abol-
ished by either treatment, the percentage of BbHD100TFP containing cells observed microscopically (Fig. 2(a,b)) 
decreased considerably in the inhibited U937 cells in comparison to the control carrier-treated cells (percentage 
of predator-containing cells at 2 h: DMSO, 95%; CD, 65%; Ndz, 80%). The median number of bacteria counted per 
occupied U937 cell also dropped significantly in inhibitor-treated cells at 2 h compared to control carrier-treated 
cells (Median ± SD: DMSO, 22 ± 16.9; CD, 1 ± 3.756; Ndz, 3 ± 4.047, Fig. 2(a–c), for both DMSO vs CD and 
DMSO vs Ndz, P < 0.0001) as did their live recovery from the inhibitor-treated cells (Fig. 2(d)). The number of 
viable predatory bacteria recovered at 4 h (Fig. 2(d), bacterial-plaque recovery as a percentage of control at 4 h, 
CD: 12% and Ndz: 25%) dropped further from 2 h (Fig. 2(d), bacterial-plaque recovery as a percentage of control 
at 2 h, CD: 27% and Ndz: 34%) in actin-inhibited cells (2 h Vs 4 h: CD – P = 0.0083, Ndz – P = 0.0597) suggesting 
the possibility of greater sensing of intracellular bacteria leading to increased bacterial killing in the absence of 
intact cytoskeleton33. These data together strongly indicate that both F-actin and microtubules contribute to B. 
bacteriovorus uptake (Fig. 2).
Characterising U937 cytokine responses to B. bacteriovorus in comparison to known pathogens. 
As our data showed that Gram-negative B. bacteriovorus predators are able to survive inside phagocytic cells 
(Fig. 1), we were interested in understanding the levels of pro- and anti-inflammatory cytokines and chemokines 
produced during intracellular predator persistence and survival in comparison to pathogenic bacteria (We chose 
the actively phagocytosed, Salmonella Typhimurium LT2 (LT2); and the passively engulfed, K. pneumoniae KPC 
(KPC)23,34). In order to compare cytokine, IL-1β, TNF-α, IL-6 and IL-10 and chemokine, IL-8 levels in culture 
supernatants of U937 cells exposed to predatory bacteria versus pathogenic bacteria; BbHD100 were exposed 
to U937 cells by synchronous spin-assisted uptake, a method that was used for the uptake of pathogenic bac-
teria, LT2 and KPC (illustrated in Fig. S1). We also recovered and enumerated bacteria from deliberately lysed 
U937 cells at 2 h by viable bacteria-plaque or colony counts which confirmed bacterial uptake (Supplementary 
Table S1).
As expected, whilst BbHD100 predators induced the pro-inflammatory cytokines, IL-1β, TNF-α and IL-6, 
their levels were always lower in comparison to the two pathogens (KPC and LT2) tested (Fig. 3). Whereas the 
highest levels of IL-1β were detected in the culture supernatants of U937-LT2 cells, the levels measured from 
U937-BbHD100 culture supernatants were at least 8 and 4-fold lower than that detected from U937-LT2 culture 
supernatants at 24 and 48 h respectively (Fig. 3(a)). TNF-α, was detected from 2 h and its levels reached maximum 
at 4–8 h and dropped gradually in the culture supernatants of U937 cells exposed to BbHD100 predators and to 
each of the pathogenic bacteria (Fig. 3(b)). The highest amounts of TNF-α detected in U937-BbHD100 culture 
supernatants at 4–8 h was at least 2-folds lower than that induced by LT2 and KPC (Fig. 3(b)). The pleotropic 
cytokine IL-6, which is mostly pro-inflammatory in acute phases of infection35,36 was also detected in the culture 
supernatants of U937 cells exposed to HD100 and their levels gradually increased up to 48 h (Fig. 3(c)). The IL-6 
levels measured from U937-BbHD100 culture supernatants was several folds lower than that measured from 
U937- LT2 or KPC supernatant samples, with the highest levels being measured from KPC samples (Fig. 3(c)).
BbHD100 upregulated the expression of the anti-inflammatory cytokine IL-10 secreted by the PMA differen-
tiated U937 cells; levels increased up to 24 h and returned to levels similar to control U937 cells at 48 h (Fig. 3(d)). 
U937 cells alone are known to secrete IL-10 following PMA differentiation37 and for this reason we display those 
control results, rather than subtracting them from experimental data. BbHD100 also upregulated the secretion 
of chemokine, IL-8 by several folds which reached its maximum at 48 h (Fig. 3(e)). However, the IL-10 and IL-8 
levels detected in U937-BbHD100 culture supernatants were lower than that measured from LT2 or KPC culture 
supernatants (Fig. 3(d,e)).
To compare the cytokines levels induced by BbHD100 exposed to U937 cells by synchronous spin uptake 
method to that by direct 2 h uptake method used in other experiments described in the manuscript, parallel 
experiments were performed where BbHD100 were exposed to U937 cells by direct 2 h uptake and cell culture 
supernatants were collected over 48 h (Fig. S1). The cytokines measured in these experiments followed a similar 
trend to that observed in the BbHD100 synchronous spin-assisted uptake experiments (Fig. S4). Overall, in both 
experiments. (c) B. bacteriovorus detected inside U937 cells that were exposed to BbHD100TFP for 2 hours at a 
MOE of 50 bacteria per cell in the presence of cytoskeletal inhibitors or carrier, DMSO were counted from the 
restored z-stack images of fixed and immunostained cells. Data shown, as number of BbHD100TFP visualised 
per cell, are representative of one of the two independent experiments, each set up in duplicate and a minimum 
of 125 cells were analysed from each experiment. ****corresponds to P < 0.0001. (d) U937 cells, pretreated with 
inhibitors, were exposed to BbHD100 for 2 hours at a MOE of 50 bacteria per cell, in the presence of inhibitors. 
Bacteria were recovered from U937 cells at 2 and 4 h and enumerated by bacterial-plaque assay. Data shown, 
as PFU/mL, are representative of mean ± standard deviation of three independent experiments, each set up in 
duplicate for U937-BbHD100 exposures and included technical replicates for bacterial-plaque enumerations 
(n = 12). At 2 h, for Control (DMSO) vs Cytochalasin D, *corresponds to P = 0.0164 and for Control (DMSO) 
vs Nocodazole, *corresponds to P = 0.0195. At 4 h, for Control (DMSO) vs Cytochalasin D or Nocodazole, 
****corresponds to P < 0.0001.
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direct and synchronous uptake protocols, BbHD100 induced cytokine levels were lower than that induced by 
known pathogens LT2 and KPC (Figs 3 and S4). We also conducted additional cytokine analyses, from direct 
uptake experiments, for U937 cells with enumerated intracellular B. bacteriovorus (from Fig. 1(a)). These were to 
validate the live numbers of intracellular predators at the same time as the cytokine measurements, but experi-
mentally did not allow simultaneous pathogen comparisons due to enumeration complexity at short timepoints. 
Those experiments also gave similar trends and peak timings of cytokine stimulation to all the results in Figs 3 & 
S4 (data not shown).
Viability of U937 cells is not greatly reduced by exposure to B. bacteriovorus. Many Gram-negative 
bacteria are known to be cytotoxic and inducers of host cell death38. Whilst previous studies have assessed the 
cytotoxic effects of B. bacteriovorus without intracellular quantification of predators12,13,15,18, we were interested 
in studying this in more detail by fluorescence microscopy in an attempt to visualize the internalized B. bacterio-
vorus and correlate their persistence and number with U937 cell viability. U937 cells exposed to BbHD100CFP at 
a MOE of 50 bacteria per cell were stained for live and dead phenotype using LIVE/DEAD Viability/Cytotoxicity 
Kit for mammalian cells (Molecular probes, Invitrogen) and analysed by widefield fluorescence microscopy that 
allowed the simultaneous imaging of live (green) and dead (red) U937 cells with the tiny individual fluorescent 
BbHD100CFP predators (blue), which we were able to detect as being intracellular to live U937 cells at all time 
points (Fig. 4(a)). BbHD100CFP caused a very low percentage of U937 cell death at 4 h (93 ± 2.16% live cells, 
7 ± 2.16% dead cells) and this was similar to the percentage of live (91.2 ± 2.72%) and dead (8.8 ± 2.72%) cells pres-
ent in the non-predator-exposed control U937 cells (Fig. 4(b)). BbHD100CFP did not cause any further U937 cell 
death at the later time points (8 and 24 h) in comparison to the control U937 cells tested at the same time points (by 
two-way ANOVA analysis, at all time points, Live cells – P < 0.7978, Dead cells – P < 0.7973, Fig. 4(b)).
We also assessed U937 cell viability after exposure to BbHD100 predators (direct 2 h uptake) in comparison 
to control U937 cells by measurement of LDH released from damaged cells into the culture supernatants. The 
Figure 3. Cytokine responses induced by B. bacteriovorus in comparison to pathogens S. Typhimurium LT2 
and K. pneumoniae KPC. BbHD100, S. Typhimurium LT2 and K. pneumoniae KPC were exposed to U937 cells 
by synchronous spin-assisted uptake at MOEs of 50:1 and 10:1 and cell culture supernatants were collected at 
various time points as illustrated in Fig. S1. The levels of cytokines (IL-1β (a), TNF-α (b), IL-6 (c), IL-10 (d) and 
IL-8 (e)) present in the supernatants of the bacteria-exposed U937 cells, collected at 2, 4, 8, 24 and 48 h, were 
measured by ELISA set up in triplicates for each individual supernatant sample collected. For pathogens, the 
2-hour time points in all panels represent cytokines produced during gentamycin treatment and the subsequent 
time points show cumulative cytokine production from 2 h onwards. The cytokine concentrations shown as 
pg/mL are representative of mean ± standard error of values from three (BbHD100 and K. pneumoniae KPC 
(n = 18)) or two (S. Typhimurium LT2 (n = 12)) independent experiments, each set up with two technical 
replicates for U937-predatory/pathogenic bacteria exposures.
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Figure 4. Viability of U937 cells exposed to B. bacteriovorus. BbHD100CFP were exposed to U937 cells for 
2 h at a MOE of 50:1 and the exposed U937 cells were stained with Calcein (live cells, green) and EthD-1 (dead 
cells, red) and imaged live at 4, 8 and 24 h. (a) Shown are representative images of live/dead stained control 
and BbHD100CFP containing U937 cells at 4, 8 and 24 h. The images were generated by merging snapshots 
of live and dead cells stained with Calcein AM (green) and EthD-1 (red) with/without BbHD100CFP, imaged 
as z-stacks, restored and 2D projected at maximum intensity (blue). Scale bar −10 µm. The images were 
acquired using 60x lens (a.1) and 100x lens (a.2). (b) Percentage of live and dead cells: the stained live and 
dead cells that were exposed to BbHD100CFP were counted and the percentages of each population of cells 
present were calculated. The percentage of live and dead cells counted at different time points in the control 
and BbHD100CFP exposed U937 cells were not significantly different (Live cells – P < 0.0934, Dead cells – 
P < 0.1292). Data shown, as percentages, are representative of mean ± standard deviation of three independent 
experiments (n = 3). A minimum of 200 cells were counted from each independent experiment at each time 
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percentage of viable cells present in control and predator exposed U937 cells were similar at time points 2, 4 and 
8 h and a small drop in total cell viability was detected at 24 h in comparison to control cells (Fig. 4(c), Control 
cells: 86.70 ± 2.68%, BbHD100 exposed cells: MOE 50:1–78.72 ± 4.04%, MOE 10:1–77.11 ± 4.42%)). Together, the 
microscopic assessment of live/dead stained U937 cells with BbHD100CFP and measurement of LDH released into 
cell culture supernatants show that internalised B. bacteriovorus does not strongly affect U937 viability up to 24 h.
B. bacteriovorus are trafficked into acidic vacuoles through the phagolysosomal pathway. As 
we were able to both detect and count individual BbHD100TFP and BbHD100CFP inside U937 cells, we were 
interested in understanding the intracellular trafficking and fate of B. bacteriovorus inside these phagocytic cells. 
To this end, two different experiments involving labelling of acidic vacuoles with lysotracker and staining of 
phagolysosomal markers were performed on separate occasions.
In order to determine whether the engulfed B. bacteriovorus were trafficked through the phagolysosomal deg-
radation pathway, the acidic vacuoles of U937 cells exposed to BbHD100TFP for 2 h by direct uptake were stained 
with LysoTracker Red DND-99 that stains late phagosomes (~pH 5), phagolysosomes (~pH 4.5) and lysosomes 
(pH 4.6–5.0)21,39. The BbHD100TFP-containing U937 cells were imaged at 4, 8 and 24 h and the co-localisation of 
BbHD100TFP with the LysoTracker stained vacuoles was assessed (Fig. 5). Co-localisation of BbHD100TFP with 
lysotracker stained vacuoles was detected at 4, 8 and 24 h (Fig. 5(a), Video 1). The fraction of bacteria co-localising 
with LysoTracker was significantly higher at 24 h in comparison to the earlier time points (8 h vs 24 h, P < 0.0001, 
Fig. 5(b)). These results were indicative of the trafficking of BbHD100TFP into acidic vacuoles.
To further investigate the localisation of B. bacteriovorus within different phagosomal compartments, 
BbHD100CFP were exposed to U937 cells at an MOE of 200:1 for 15 minutes in a smaller volume (200 µL) to 
promote rapid uptake. The free bacteria were removed by washing and the cells fixed and immunostained for the 
early and late phagosomal markers at 20 min, 40 min, 1 and 2 h. B. bacteriovorus were found inside early phago-
somal marker, EEA1-labelled vacuoles as early as 20 minutes (Fig. 6). We also detected BbHD100CFP associated 
with late phagosomal markers, Rab7 and LAMP1 from 40 min onwards with the association being strongest at 
1 hr (Fig. 6). This co-localisation of B. bacteriovorus within acidic vacuoles and association with phagosomal 
markers strongly indicate the trafficking of predators through the phagolysosomal pathway of degradation.
serum antibodies to B. bacteriovorus are detectable but generally low in Human populations. 
Having measured the persistence of viable B. bacteriovorus and their processing by the phagolysosomal pathway, 
it is important to consider whether recognition and clearance of predatory bacteria by the immune system could 
negate its activity or use as a future treatment. As our current study indicates the possibility for the bacteria to 
be presented to CD4 T-helper cells which could result in B-cell activation and subsequent antibody production, 
we measured the prevalence and level of antibodies to predators in the general human population using serum 
samples obtained from Nottingham Health Services Biobank (https://www.nottingham.ac.uk/cancerresearchnot-
tingham/resources/nottingham-tissue-biobank/nottingham-tissue-biobank.aspx) where ethically pre-approved 
donations of human samples are stored. (Ethical approval for generic consent for prospective collections and 
for the use of Pathology archival material at the Biobank has been granted by the Greater Manchester National 
Research Ethics Service). Two standard recall antigens to which humans are exposed from vaccination or envi-
ronmental exposure, Tetanus toxoid and Candida albicans surface antigen, were used as positive controls to con-
firm the presence of antibodies in the serum samples tested. As the positive controls were purified antigens, levels 
of responses to them were not directly comparable to lysed B. bacteriovorus or our chosen control bacterium, 
Escherichia coli. For C. albicans only, 5 results had to be extrapolated from above the top point, (shown by dotted 
line), on the standard curve but as these were a positive control for antibody production competence of the serum 
donors this was deemed acceptable. All other values were measured within standards.
In our studies, IgG and IgM antibodies against both predators (BbHD100, a lab strain and B. bacteriovorus 
Tiberius (BbTiberius), a recent environmental isolate of B. bacteriovorus from a river40) were detected in more 
than 90% of samples tested (Fig. 7). Even though highest concentrations of 76.87 µg/mL and 56.72 µg/mL of 
anti-BbHD100 and anti-BbTiberius IgG antibodies respectively were measured for one individual sample, around 
50–60% of the total samples analysed had an antibody concentration that was less than 10 µg/mL (Fig. 7). The 
concentrations of IgM antibodies detected against both the predators were lower than that of IgG antibodies indi-
cating that the exposure of serum donors to B. bacteriovorus was not recent (Fig. 7).
Again, around 70% of the total population analysed had an IgM concentration that was less than 10 µg/mL. 
IgA antibodies were also detected against both predators with the highest concentrations being 3.332 µg/mL and 
24.949 µg/mL of anti-BbHD100 and anti-BbTiberius antibodies respectively (Fig. 7). However, in more than 50% of 
the population, there were no detectable levels of IgA antibodies. The presence of anti-B. bacteriovorus antibodies in 
the general human population reminds us of the natural, apparently safe, exposure of humans to predators in nature.
Discussion
For B. bacteriovorus to realise its potential as a live, non-traditional, therapy for Gram-negative bacterial infec-
tions in humans, it is crucial to understand the interactions with and fate of these predatory bacteria inside 
human immune cells. What are the processes involved in their uptake by phagocytic cells? Would these predatory 
bacteria survive in the host cells and for how long? What immune response would be induced as these predatory 
point. (c) U937 cell viability was assessed by measurement of LDH released from damaged cells into the 
culture supernatants at 2, 4, 8 and 24 h from control and BbHD100 predator exposed cells. The data shown are 
representative of mean ± standard deviation of values from at least three independent experiments.
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bacteria persist inside host cells? And how ultimately are these non-pathogenic bacteria cleared by the host? 
Whilst several recent studies have verified the safety of predators using in vitro cell culture models12–14 and in vivo 
animal models9,11,15–18, the live persistence and fate of predatory bacteria within the cells of the immune system 
has not yet been investigated. In this current study, we have tracked B. bacteriovorus engulfment, visualised these 
tiny bacteria using fluorescent microscopy and recovered and enumerated viable predators in order to understand 
their intracellular fate.
We postulated that non-pathogenic B. bacteriovorus are recognised and taken up by host cell phagocytosis 
and do not manipulate the host cytoskeleton actively (to be expected as they lack type III secretion system genes 
responsible for host cell manipulation25). By performing bacterial uptake experiments in the presence of phar-
macological inhibitors, we demonstrated a significant role of the host actin cytoskeleton and its rearrangement 
and microtubule dynamics in the uptake of B. bacteriovorus HD100. An inhibitor-associated reduction in uptake 
of B. bacteriovorus HD100 was observed at 2 h by fluorescence microscopy and counting and by viable plaque 
enumeration. A further reduction in the recovery of viable predatory bacteria was observed at 4 h, implying an 
effect of intact host cytoskeleton in the persistence of B. bacteriovorus HD100.
Perturbation of actin remodelling has been shown to enhance NOD2 receptor-dependent NF-κB signalling, 
sensing of bacteria and stimulation of inflammatory immune responses33,41. Hence disruption of actin cytoskele-
ton with cytochalasin D or the disassembly of microtubule network with nocodazole, which in turn can influence 
Figure 5. Trafficking of B. bacteriovorus inside U937 cells. BbHD100TFP were exposed to U937 cells for 
2 hours at a MOE of 50:1 and the acidic vacuoles of the cells were labelled with LysoTracker red DND-99 and 
imaged live at 4, 8 and 24 h. (a) Shown are representative images (single slices from restored z-stacks) of U937 
cells (Nuclei stained with Vybrant DyeCycle Violet, blue) containing BbHD100TFP (green) with labelled acidic 
vacuoles (red) at 4, 8 and 24 h from one of the two independent experiments. The red and green arrows in the 
LysoTracker and BbHD100TFP channels point to specific acidic vacuoles and BbHD100TFP respectively. The 
yellow/white arrows in the merged images show colocalisation/no colocalisation respectively of predatory 
bacteria with the acidic vacuoles. Scale bar −5 µm. (b) Box plots with each point corresponding to the fraction 
of bacteria colocalising with the labelled acidic vacuoles in a cell at the time points, 4, 8 and 24 h. A minimum 
of 100 cells with predatory bacteria were analysed in each experiment at each time point and the data shown 
are the combined values from two independent experiments (n = 100 cells per experiment). ****corresponds 
to P < 0.0001. Video 1 (a and other samples). Video of z-stack images taken across U937 cells (one taken from 
(a) above) with HD100TFP and labelled with LysoTracker red DND-99 at 4, 8 and 24 h time points. Video 1a 
corresponds to experiment 1 and video 1b corresponds to experiment 2.
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actin remodelling via Rho GTPases42, could have led to further sensing and killing of internalised B. bacterio-
vorus HD100 that we observed at the later experimental time point by artificially changing actin polymerization. 
However our studies did not test for actin/microtubule changes caused by B. bacteriovorus because they do not 
encode Type III secretion systems25 which other pathogenic bacteria use to manipulate host actin43. In addition, a 
recent publication44 highlights further complex dynamics between cell division of internalized bacteria and host 
cell septin response, which leads to their entrapment and delivery to lysosomes. Both of these cytoskeletal inter-
actions could be the subject of further experimental studies but their scope is beyond that of this current study.
Once taken up, B. bacteriovorus HD100 survive at relatively high numbers up to 8 h, and can be recovered 
and enumerated up to 48 h, without a resulting loss in host cell viability (measured up to 24 h). It is noteworthy 
that B. bacteriovorus cannot replicate inside host cells as there is no source of prey bacteria25 which is in contrast 
to intracellular pathogenic bacteria that can replicate inside phagocytic cells. Following the observation of the 
intracellular survival of this non-pathogenic predatory bacterium, it is important to consider the nature of the 
immune response as B. bacteriovorus HD100 persist. Intracellular replicative pathogens such as S. Typhimurium 
and M. tuberculosis modulate pro-inflammatory and anti-inflammatory cytokine responses to assist their persis-
tence and multiplication inside host cells45,46. As expected for a Gram-negative bacterium, U937 cells mount an 
immune response on exposure to B. bacteriovorus HD100, but the levels measured for all cytokines were lower 
than those induced by pathogens, S. Typhimurium LT2 and K. pneumoniae KPC which were tested alongside. 
One of the first pro-inflammatory cytokines to be released in response to a pathogen is TNF- α47; non-pathogenic 
B. bacteriovorus induced moderate levels of TNF-α, the concentrations of which reached a maximum by 4–8 h 
which corresponded with the high number of viable predators recovered from the macrophages.
TNF-α is known to cross talk to ROS production in processes, for other internalized bacteria, which affect 
apoptosis by induction of mitochondrial permeabilisation contributing to apoptosis via the Bcl2 pathway. Studies 
are ongoing in our laboratory measuring the transcriptional host response to the presence of B. bacteriovorus. 
These and a future specific programme to test ROS induction and associated apoptosis in host are beyond inclu-
sion in this work, but of important interest for the future. We note that at high levels of TNF-α, there were still 
significant levels of viable internalized B.bacteriovorus so an extensive time series of any ROS stimulation and its 
correlation with recoverable B. bacteriovorus is required48,49.
B. bacteriovorus induced very low levels of IL-1β, a pro-inflammatory cytokine whose maturation is trig-
gered by the inflammasome that can also simultaneously trigger cell death by pyroptosis50,51. This response corre-
sponded well with the low percentage of U937 host cell death observed up to 24 h (maximum of 10%) following 
B. bacteriovorus exposure. B. bacteriovorus induced IL-6 levels, a pleotropic cytokine and a strongest activator 
of acute phase response during bacterial infections36, IL-6 increased over time and its levels were lower than 
that induced by the pathogens included in our study. B. bacteriovorus HD100 upregulated IL-10 production by 
U937 cells, an important anti-inflammatory cytokine which is a known inhibitor of pro-inflammatory cytokines 
including IL-6, IL-12 and TNF-α52 and also a negatively regulator of inflammasome activation through inhi-
bition of mTOR (mammalian target of rapamycin) signalling resulting in inhibition of IL-1β maturation53. B. 
Figure 6. Colocalisation of B. bacteriovorus with early and late phagosomal markers. BbHD100CFP were 
exposed to U937 cells for 15 min at a MOE of 200:1 in a smaller volume (200 µl) to promote rapid uptake of 
the predatory bacteria. The cells fixed at time points, 20 min, 40 min, 1 h and 2 h were immunostained for the 
early phagosomal marker EEA1 and late phagosomal markers Rab7 and LAMP1. Shown are the representative 
maximum intensity 2D-projections of restored z-stack images of U937 cells with BbHD100CFP (blue), 
immunostained for the phagosomal markers (false coloured in red), taken at time points 20 minutes (EEA1) 
and 1 h (Rab7 and LAMP1). The magnified images of the merged panel are representative regions showing the 
predatory bacteria colocalising with the phagosomal markers. A minimum of 100 cells with BbHD100CFP were 
analysed at each time point to study colocalisation of predators with phagosomal markers. Scale bar −5 µm.
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bacteriovorus HD100-induced IL-10 levels reached their highest by 24 h which might have contributed to the 
dampening of IL-1β and TNF-α response at later time points by potential signalling of secreted IL-10 through 
IL-10 receptors which are upregulated on differentiated U937 cells29. Intracellular pathogenic bacteria such as S. 
Typhimurium used in our study as positive controls, commonly induce/upregulate IL-10 production by signalling 
through C-type lectins54 and Toll-like receptors52 to aid in the establishment of infection55,56. Commensals such 
as Bacteroides fragilis induce IL-10 secretion by resident macrophages to dampen pro-inflammatory cytokine 
responses and aid bacterial persistence57. The upregulation of IL-10 production by U937 cells by B. bacteriovorus 
HD100 measured in this current study may aid the observed persistence and survival of the predatory bacteria 
inside macrophages. In our study, B. bacteriovorus HD100 were able to stimulate increasingly high levels of IL-8 
production by U937 cells, a widely studied chemokine that mediates recruitment of neutrophils to the site of 
infection and promotes phagocytosis47. However, IL-8 from pathogen exposed cells were at least 1.5 fold higher 
than that induced by B. bacteriovorus HD100. These data expand upon recent safety and cytokine studies, using 
different epithelial, monocyte and macrophage cell lines12–14 and in vivo models9,15–18 by adding the intracellular 
enumeration of live predators so that the detection and survival of live intracellular predators informs cytokine 
response and host cell viability assays. We can see both the available predatory potential of the predators for infec-
tion treatment, but at the same time that any inflammatory or viability “costs” to host cells are not high.
Despite its viable persistence for many hours, B. bacteriovorus HD100 is ultimately trafficked into the phago-
lysosomal pathway of clearance and antigen presentation as evidenced by their targeting into acidic vacuoles. The 
localization of B. bacteriovorus HD100 inside acidic vacuoles increases with time as observed for other bacteria 
such as Coxiella burnetii58 and Legionella pneumophila59. Our analysis showed the highest level of colocalisation 
of B. bacteriovorus HD100 with LysoTracker labelled acidic vacuoles at 24 h, the time point at which bacterial 
recovery on plaque plates were significantly lower than at 8 h. The predatory bacteria trafficked into acidic vacu-
oles are likely to be under the process of degradation and may not be viable to form plaques (on E.coli lawns in our 
assays), which likely accounts for low bacterial recovery at 24 h in contrast to the number of bacteria visualised 
and counted by fluorescence microscopy. As mentioned before, unlike more conventional bacteria including 
pathogens, B. bacteriovorus HD100 require live bacterial prey for their replication25. Hence it is very unlikely for 
predatory B. bacteriovorus to multiply inside acidic vacuoles in the absence of prey as seen with other bacteria 
such as C. burnetii19,58 and L. pneumophila24,59. They also may not be able to break out from lysosomal compart-
ments to be released into the cytoplasm which is typical for cytosolic bacteria such as Shigella as they lack the 
type III secretion system that is crucial for phagosome escape25,60. These findings together suggest that predatory 
bacteria are processed through the phagolysosomal pathway but it is possible that non-replicative and therefore 
“stealthy” behaviour of B. bacteriovorus may account for some of the persistence and delay in phagolysosomal 
processing seen for predators inside phagocytic cells.
The uptake of predatory bacteria by phagocytic cells could result in the processing and presentation of bac-
terial antigens to the CD4 helper T cells resulting in humoral and cell-mediated immune responses in the wider 
host. B. bacteriovorus are found ubiquitously in soil and water, and so humans are naturally exposed to them. 
16S rRNA studies have detected the presence of B. bacteriovorus in the guts of healthy young adults and in the 
Figure 7. Prevalence of antibodies against B. bacteriovorus in general human populations. Human serum 
samples obtained from the Nottingham Health Services Biobank were tested for the presence of antibodies (IgG, 
IgM and IgA) against BbHD100 and BbTiberius by direct antigen ELISA with streptavidin-biotin detection. 
Written consent was obtained from all patients and the study was approved by North West 7 REC – Greater 
Manchester Central (ethics reference 15/NW/0685). Lysed BbHD100 and BbTiberius with total cell protein 
matched to lysed E. coli control (10 µg/ml) were used as coating antigens. The recall antigens, Tetanus toxoid (2 
LF/ml) and Candida albicans surface antigen (1 µg/ml) were used as positive controls for antibody presence for 
the ELISA. Data shown are the antibody responses analysed from 25 different serum samples and median values 
for each antigen are represented as a line. Dotted line, denoted LOD represents the upper limit of detection for 
IgA; 5 values for C. albicans IgA only, were higher than the top standard and so were extrapolated. All other IgA 
and all IgG and IgM values were within the standard curve.
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lung microbiome of CF patients who have pathogenic bacterial colonization61,62. Recently antibodies against B. 
bacteriovorus were reported by dot blot analysis using pooled human serum63. Our U937 work here shows that 
live B. bacteriovorus are recoverable and may persist significantly within the immune systems of humans, giving 
the signals in those prior studies.
While full studies of bodily persistence of applied B. bacteriovorus treatments in humans are beyond the scope 
of our current project, our survey of anti-B. bacteriovorus antibodies in healthy human populations have shown 
the presence of variable, but usually low levels of IgA, IgG and IgM antibodies to both B. bacteriovorus predators, 
HD100, a lab strain isolated from soil and Tiberius, a recently isolated predator-strain from river water40. These 
results show that environmental exposure to B. bacteriovorus is recognised by human populations, but that there 
is not a large circulating antibody titre to them in most humans. This and the other data in our paper, show that a 
single therapeutic dose of B. bacteriovorus against multi-drug resistant infections has chance to act, before clear-
ance of predatory bacteria by host immune recognition.
In conclusion, this study explores and provides knowledge on the intracellular fate of predatory bacteria, an 
important consideration if Bdellovibrio bacteriovorus is to be administered as a live therapy. B. bacteriovorus are 
engulfed and persist inside human macrophage-like cells for 24 h without affecting host cell viability while stim-
ulating moderate cytokine responses, lower than that seen for pathogens including S. Typhimurium LT2 and K. 
pneumoniae KPC. We have demonstrated that the host cytoskeleton, (not the predator), facilitates the phagocytic 
uptake of B. bacteriovorus HD100 in its bacterially-predatory state and the engulfed predators are able to persist 
inside macrophages in a non-replicative but predatorily competent state before being processed through phago-
lysosomal degradation pathway over 24–48 h.
The timeframe of viable predator persistence, without extensive inflammatory or host cell viability effects, 
defined in this study provides a period that could be exploited therapeutically as the predatory bacteria may 
be available to encounter and prey upon intracellular Gram-negative pathogens such as Salmonella30,64 and 
Klebsiella23. Alternatively, the relatively benign occupancy of the macrophages by B. bacteriovorus HD100 could 
prevent further ingress and spread of intracellular bacterial pathogens. It may be that predators require extra, 
engineered factors to prey on pathogens in such environments which is a subject of a further extensive study, but 
our data presented provide an opportunity and basis for further study.
Methods
B. bacteriovorus preparation and enumeration. Cultures of BbHD100, BbTiberius and the fluores-
cent-tagged strains, BbHD100TFP (Bd0064: mTeal)10 and BbHD100CFP (Bd0064: mCerulean3, this study) were 
grown predatorily on prey in liquid or agar plates and enumerated as described previously10,34,65,66. Detailed pro-
cedures for culturing and enumeration of B. bacteriovorus and information on fluorescent-tagged strains can be 
found in supplementary methods.
U937 cell culture and differentiation. U937 (ATCC CRL-1593.2, Lot number 62113514, from LGC 
Standards, UK), a human monocyte-like cell line29,67 was obtained directly for these studies and validated by the 
STR profile of the supplier. It was grown in suspension in RPMI supplemented with 10% FBS, 4.5 g/L glucose, 2 
mM L-glutamine, 10 mM HEPES, 1 mM Sodium Pyruvate, 1.5 g/L Sodium Bicarbonate, 1 U/ml penicillin and 
100 µg/ml streptomycin (all Sigma-Aldrich) at 37 °C, 5% CO2. U937 cells were seeded at 5 × 105 cells/ml in T-75 
flasks (Corning) and differentiated into macrophage-like cells by addition of 100 nM PMA (Phorbol 12-myristate 
13-acetate, Sigma-Aldrich) for 48 h at 37 °C, 5% CO226. FACS analysis of CD11b cell surface marker expression 
was used to confirm differentiation of the U937 cells after PMA treatment (Fig. S5). The adhered cells were har-
vested by gentle cell scraping, washed in Dulbecco’s PBS (D-PBS) (0.2 g/L KCl, 0.2 g/L KH2PO4, 8 g/L NaCl and 
2.1716 g/L Na2HPO4.7H2O, pH: 7.4), Sigma-Aldrich) by centrifugation at 300 × g for 10 minutes and counted. 
For all assays, the cells were seeded in fresh medium without PMA and were allowed to adhere overnight for 
about 18 h at 37 °C, 5% CO2.
B. bacteriovorus exposure to U937 cells for microscopic analysis, enumeration of viable preda-
tors and collection of culture supernatants. To study engulfment of predatory bacteria by U937 cells, 
BbHD100, resuspended in D-PBS, were diluted appropriately in fresh antibiotic-free culture medium to give 
MOEs of 10:1 and 50:1 and were added in duplicate (for MOE 10:1, 2 × 106 PFU of bacteria/well and for MOE 
50:1, 1 × 107 PFU of bacteria/well) to U937 cells seeded in 24-well plates (2 × 105 cells/well) from which the spent 
medium was removed and washed once in wash buffer [D-PBS with calcium and magnesium chloride (0.1 g/L 
each), Gibco and 5% FBS] and incubated at 37 °C, 5% CO2. After 2 h uptake, BbHD100 containing medium was 
removed, the cells were washed twice in wash buffer and fresh antibiotic-free culture medium was added. At 2, 4, 
8, 24 and 48 h, the cells were lysed in 1 mL of ice-cold water for 10 minutes after two washes in wash buffer. The 
lysates were serially diluted and bacterial-plaque plates were prepared for enumeration of viable BbHD100. Live 
recovered B. bacteriovorus numbers were presented as PFU/ml, with 1 ml corresponding to the whole contents 
of a single well, from a 24-well plate, seeded with 2 × 105 U937 cells. Numbers were presented as such because 
we could not recover and count both U937 cells and bacteria for counting from the same well and thus using 
standardised procedures for lysis and standardised seeding and bacterial exposure, this was the fairest way to 
represent the data.
In a separate experiment to compare the levels of cytokines induced by BbHD100 in comparison to known 
pathogenic bacteria, U937 cells were exposed to BbHD100, S. Typhimurium LT2 and K. pneumoniae KPC and 
supernatants were collected over 48 h as described in supplementary methods (illustrated in Fig. S1). In a parallel 
experiment, supernatants were also collected from U937 cells exposed to BbHD100 by direct 2 h uptake (illus-
trated in Fig. S1). The collected supernatants were centrifuged at 17000 × g for 15 minutes, at room temperature 
(RT) to pellet and remove cell debris and were used in cell viability and cytokine assays.
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To understand the role of cytoskeleton in B. bacteriovorus uptake, U937 cells were pre-treated with cytoch-
alasin D (10 µM) or Nocodazole (2.5 µM) (both from Sigma-Aldrich) or carrier reagent, DMSO for 1 hour and 
BbHD100 diluted appropriately in medium containing inhibitors or DMSO were added at a MOE of 50:1 and 
incubated for 2 h at 37 °C, 5% CO2 as described above. The inhibitors were used at effective concentrations at 
which cells and B. bacteriovorus viability were not affected and were based on our own supporting experiments 
and previous publications68,69. After uptake, the BbHD100 containing medium was removed and the cells were 
washed twice in wash buffer. Another set of cells exposed to BbHD100 under same conditions were incubated in 
culture medium with inhibitors/DMSO for further 2 h at 37 °C, 5% CO2. At time points, 2 and 4 h, the cells were 
washed twice in wash buffer, lysed and bacterial-plaque plates were prepared from serially diluted samples.
For microscopic analysis of engulfed predatory bacteria, BbHD100CFP, diluted appropriately in fresh antibi-
otic–free culture medium to give a MOE of 10:1 (4 × 106 PFU of bacteria/chamber) or 50:1 (2 × 107 PFU of bac-
teria/chamber) were added in duplicate to Nunc Lab-Tek II chamber slides seeded with U937 cells (4 × 105 cells 
per chamber). After 2 h, the bacteria containing medium was removed, the cells were washed twice in wash buffer 
and incubated in fresh antibiotic-free culture medium. At 2, 4, 8 and 24 h time points, the cells were washed once 
in wash buffer, fixed in 4% formaldehyde for 10 min at RT, the nuclei were stained and imaged using widefield flu-
orescence microscope. In a separate experiment, U937 cells seeded in Greiner CellView (Advanced TC surface) 
chamber slides (Greiner Bio One) at 1 × 105 cells per chamber were pre-treated with cytochalasin D (10 µM) or 
Nocodazole (2.5 µM) or DMSO for 1 hour and then BbHD100TFP (5 × 106 PFU/well of bacteria) were added at a 
MOE of 50:1 and incubated for 2 h at 37 °C, 5% CO2 in the presence of inhibitors or carrier. After a 2-hour uptake 
period, the bacteria containing medium was removed, the cells were washed twice in wash buffer and fixed in 
4% formaldehyde for 10 min at RT. The fixed U937 cells were permeabilised, immunostained and imaged using 
widefield fluorescence microscope. In a third experiment to visualise intracellular predators by confocal micros-
copy, BbHD100TFP were added to U937 cells seeded in Greiner CellView (Advanced TC surface) chamber slides 
(Greiner Bio One) at a MOE of 50:1 as described above and the cells were fixed in 4% formaldehyde for 10 min 
at RT at 2 h post-uptake. The fixed U937 cells were permeabilised, immunostained and imaged using confocal 
fluorescence microscope. Further details on immunostaining, microscopy and image analysis can be found in 
supplementary methods.
Cytokine assays. IL-1β, IL-6, and TNF-α were measured using Duoset ELISA kits (R&D Systems, Abingdon, 
UK) according to the manufacturers’ protocol using the suggested antibodies and cytokine standards. IL-8 and 
IL-10 were measured using Human ELISA Ready-SET-Go kits (Affymetrix Ebioscience, UK) according to the 
manufacturers’ protocol. Sample absorbance at 450 nm was measured using a FLUOstar Omega multi-mode 
microplate reader (BMG Labtech, Aylesbury, UK) and the values were interpolated with standard curves using 
Prism 7.0 (Graphpad Software Inc.).
Lysotracker and immunofluorescence staining of phagolysosomal compartments. For staining 
and co-localisation analysis of acidic vacuoles with B. bacteriovorus, BbHD100TFP (5 × 106 PFU/well of bacte-
ria) were exposed to U937 cells seeded in Greiner CellView (Advanced TC surface) chamber slides (Greiner Bio 
One) at 1 × 105 cells per chamber for 2 h at an MOE of 50:1. Following this, the bacteria-containing medium 
was removed, the cells were washed twice in wash buffer and fresh antibiotic-free culture medium was added 
to the chambers slides and incubated at 37 °C, 5% CO2. The acidic vacuoles and nuclei of the cells were labelled 
with LysoTracker (50 nM, Molecular probes, Life Technologies) and Vybrant DyeCycle Violet (0.5 µM, Molecular 
probes, Invitrogen) respectively at 30 min prior to the time points, 4, 8 and 24 h and the live cells were imaged by 
widefield fluorescence microscopy.
For immunocytochemical studies of early and late phagosomal markers in B. bacteriovorus exposed U937 
cells, BbHD100CFP, diluted appropriately in fresh antibiotic–free culture medium to give a MOE of 200:1 (8 × 107 
PFU of bacteria/chamber in 200 µL medium) were added to U937 cells seeded in Nunc Lab-Tek II CC2 chamber 
slides (4 × 105 cells per chamber). After 15 minutes, the bacteria-containing medium was removed and replaced 
with fresh antibiotic-free culture medium after two washes in wash buffer. At time points, 20 min, 40 min, 1 and 
2 h from initial exposure, appropriate cell samples were washed once in wash buffer and fixed in 4% formaldehyde 
for 10 minutes at RT, permeabilised and immunostained for EEA1, Rab7 and LAMP1 and imaged using widefield 
fluorescence microscope. Further details on immunostaining, microscopy and image analysis can be found in 
supplementary methods.
Assessment of U937 cell viability - By microscopy of live/dead stained cells and LDH measure-
ment. Microscopic assessment of U937 cell viability was carried out using LIVE/DEAD Viability/Cytotoxicity 
Kit for mammalian cells (Molecular probes, Invitrogen). U937 cells were seeded and exposed to BbHD100CFP as 
described in the section for BbHD100TFP for lysotracker labelling. At time points, 4, 8 and 24 h, live/dead stain 
(live cells stained by Calcein AM (0.1 µM) and dead cells stained by Ethidium homodimer-1 (EthD-1) (1 µM)) 
was added to appropriate samples and incubated for further 20 min at 37 °C, 5% CO2. The stained cells, as well 
as the intracellular BbHD100CFP, were imaged live using widefield fluorescence microscope. Further details on 
microscopy and image analysis can be found in supplementary methods.
U937 cell viability was also assessed by measurement of LDH released into the cell culture supernatants 
after exposure of the phagocytic cells to BbHD100 predators (by 2 h direct uptake) using Promega CytoTox 96® 
Non-Radioactive Cytotoxicity Assay Kit as per the manufacturer’s instructions. Total number of dead U937 cells 
per sample was calculated from a standard curve generated by plotting absorbance at 490 nm against total LDH 
released from lysed control U937 cells. Percentage U937 cell viability was then calculated using the formula: (total 
number of cells per well – total number of dead cells per well) × 100.
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eLIsA for assessment of serum antibodies in human populations reacting to lysed B. bacteri-
ovorus components. IgG, IgM and IgA antibodies specific for lysates of BbHD100 and BbTiberius pres-
ent in human populations were measured by ELISA using ethically collected human serum samples from the 
Nottingham Health Services Biobank, who obtained a written consent for experimentation from all patients 
before serum collection. The Biobank study was approved by North West 7 REC – Greater Manchester Central 
(ethics reference 15/NW/0685) and our methods and procedures in this study were performed in accordance 
with the relevant guidelines and regulations.
ELISA plates (Nunc Maxisorp, 96-wells) were coated overnight at 4 °C in triplicate with 50 µl of lysed bacteria 
including BbHD100 or BbTiberius or E. coli prepared by sonication of D-PBS washed cultures (pulsed 6 × 30 s 
at an amplitude of 20 microns using an exponential microprobe, Sanyo Soniprep 150) with matching total pro-
tein concentrations (10 µg/ml) along with standard recall antigens relevant to humans, Tetanus toxoid (2 LF/ml, 
NIBSC) and Candida albicans surface antigen (1 µg/ml, Jena Biosciences), no-antigen controls and immunoglob-
ulin standards. All antigens and standards were diluted in carbonate/bicarbonate buffer (Sigma-Aldrich). After 
blocking for one hour at RT with 2% BSA (R&D systems) and 0.1% Tween 20 (Sigma-Aldrich) in D-PBS, the 
plates were probed with 50 µl of human serum samples diluted 1:100 in 1% BSA (R&D systems) in D-PBS and 
incubated for 1.5 h at RT. Following this, 50 µl of the appropriate biotinylated primary antibody (1:30000 dilution, 
Biotinylated anti-human IgG; Biotinylated anti-human IgM; Biotinylated anti-human IgA) (Vector Labs) was 
incubated in the wells for 1.5 h at RT. Detection was carried out by addition of 1:40 dilution of Streptavidin-HRP 
(R&D systems), and incubation for 15 min at RT. Between each step, the plates were washed three times with 
D-PBS buffer containing 0.1% Tween 20. After three final washes, the plates were developed with TMB substrate 
(Sigma-Aldrich) and the reactions were stopped with 1 N H2SO4. Sample absorbance at 450 nm was measured 
using FLUOstar Omega multi-mode microplate reader (BMG Labtech, Aylesbury, UK) and the values were inter-
polated with standard curves using Prism 7.0 (Graphpad Software Inc.).
statistical analysis. Statistical analysis was carried out using Prism 7.0 (Graphpad Software Inc.). All data 
were tested for normal distribution by the D’Agostino- Pearson test and most of them failed. Therefore, the non-
parametric, two-tailed unpaired Mann-Whitney U test was used to analyse the data shown in Figs 1(a,c), 2(c,d) 
and 5(b) and two-way ANOVA was used to analyse the data shown in Fig. 4(b). P-values < 0.05 were considered 
to be significant and p-values were added to figure legends.
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